Risk-Benefit Assessment of Ethinylestradiol Using a Physiologically Based Pharmacokinetic Modeling Approach-Reference-Cited by-同舟云学术

Risk-Benefit Assessment of Ethinylestradiol Using a Physiologically Based Pharmacokinetic Modeling Approach

Published:2018-04-27 Issue:6 Volume:104 Page:1229-1239
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Ezuruike Udoamaka¹,Humphries Helen¹,Dickins Maurice¹,Neuhoff Sibylle¹^ORCID,Gardner Iain¹,Rowland Yeo Karen¹

Affiliation:

1. Simcyp Limited (a Certara company); Sheffield UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpt.1085/fullpdf

Reference50 articles.

1. Smyth , C. Contraception Failure Blamed for Abortions https://www.thetimes.co.uk/article/contraception-failure-blamed-for-abortions-w8ddnm5qz 2017

2. Epidemiology of oral contraceptives and cardiovascular disease;Chasan-Taber;Ann. Intern. Med,1998

3. Contraceptive hormone use and cardiovascular disease;Shufelt;J. Am. Coll. Cardiol,2009

4. U.S. Food & Drug Administration Labeling for Combined Hormonal Contraceptives: Guidance for Industry https://www.fda.gov/ucm/groups/fdagov-public/@fdagov-drugs-gen/documents/document/ucm590673.pdf 2017

5. Ethinyl estradiol and 17beta-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment;Stanczyk;Contraception,2013

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Issues Associated with Female Contraceptives;Textbook of Contraception, Sexual and Reproductive Health;2024-01-25

2. Physiologically‐based pharmacokinetic modeling of prominent oral contraceptive agents and applications in drug–drug interactions;CPT: Pharmacometrics & Systems Pharmacology;2024-01-15

3. Attempting to Unmask the Inhibition of Sulfotransferase 1E1 in 17α‐Ethinyl Estradiol Drug Interactions;The Journal of Clinical Pharmacology;2023-04-27

4. Combined Oral Contraceptives As Victims of Drug Interactions;Drug Metabolism and Disposition;2023-03-24

5. Current Practices, Gap Analysis, and Proposed Workflows for PBPK Modeling of Cytochrome P450 Induction: An Industry Perspective;Clinical Pharmacology & Therapeutics;2021-12-24